Global Custom Market Research Reports Provider Company

phone

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018

  • Published Date: 12 Jun 2018
  • Number of Pages: 36
  • Category: Pharmaceuticals
  • Country: Global
Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018

Summary

According to the recently published report Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018; Cell Division Protein FtsZ (ftsz) pipeline Target constitutes close to 9 molecules. Out of which approximately 2 molecules are developed by companies and remaining by the universities/institutes.

Cell Division Protein FtsZ (ftsz) -

The report Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2018 outlays comprehensive information on the Cell Division Protein FtsZ (ftsz) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Cell Division Protein FtsZ (ftsz) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Preclinical and Discovery stages are 1 and 1 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 2 and 5 molecules, respectively.

Report covers products from therapy areas Infectious Disease which include indications Escherichia coli Infections, Methicillin-Resistant Staphylococcus aureus (MRSA) Infections, Tuberculosis, Bacillus Infections, Enterococcus faecium Infections, Skin And Skin Structure Infections (SSSI) Caused By Bacteria, Staphylococcus aureus Infections, Streptococcal Pneumonia and Vancomycin-Resistant Enterococcus faecium Infections.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Cell Division Protein FtsZ (ftsz)
- The report reviews Cell Division Protein FtsZ (ftsz) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Cell Division Protein FtsZ (ftsz) targeted therapeutics and enlists all their major and minor projects
- The report assesses Cell Division Protein FtsZ (ftsz) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Cell Division Protein FtsZ (ftsz) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Cell Division Protein FtsZ (ftsz)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cell Division Protein FtsZ (ftsz) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Publisher Name : Global Markets Direct

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Cell Division Protein FtsZ (ftsz) - Overview
Cell Division Protein FtsZ (ftsz) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Cell Division Protein FtsZ (ftsz) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Cell Division Protein FtsZ (ftsz) - Companies Involved in Therapeutics Development
TAXIS Pharmaceuticals Inc
Cell Division Protein FtsZ (ftsz) - Drug Profiles
BIZ-20131 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BIZ-20132 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BIZ-20133 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
chrysophaentin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SBP-17GA20 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit FtsZ for Streptococcal Pneumonia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit FtsZ for Tuberculosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TXA-497 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TXA-709 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cell Division Protein FtsZ (ftsz) - Dormant Products
Cell Division Protein FtsZ (ftsz) - Product Development Milestones
Featured News & Press Releases
Sep 07, 2016: FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic:
Jun 13, 2016: Experimental Antibiotic Treats Deadly MRSA Infection
Sep 18, 2015: TAXIS Pharmaceuticals Demonstrates Synergistic Efficacy Against MRSA And Low Resistance Frequency With TXA709/Cefdinir Combination
Jun 05, 2015: TAXIS Pharmaceuticals Announces Publication of Data Demonstrating Potential Viability of TXA709 in Combating Antibiotic Resistance
Apr 27, 2015: TAXIS Pharmaceuticals Demonstrates Clinical Potential of TXA709 in Combating Antibiotic Resistance
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List Of Tables

List of Tables
Number of Products under Development by Stage of Development, H1 2018
Number of Products under Development by Therapy Areas, H1 2018
Number of Products under Development by Indication, H1 2018
Number of Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018
Number of Products under Investigation by Universities/Institutes, H1 2018
Products under Investigation by Universities/Institutes, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Pipeline by TAXIS Pharmaceuticals Inc, H1 2018
Dormant Projects, H1 2018

List Of Figures

List of Figures
Number of Products under Development by Stage of Development, H1 2018
Number of Products under Development by Top 10 Indications, H1 2018
Number of Products by Stage and Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018

Report Cell Imagers-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Imagers industry, standing on the readers perspective, delivering detailed market data and penetrating insights.

View Report

Report Cell Imagers-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Imagers industry, standing on the readers perspective, delivering detailed market data and penetrating insights. No

View Report

Report Cell Imagers-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Imagers industry, standing on the readers perspective, delivering detailed market data and penetrating insights. No

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports